Title:
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN
Document Type and Number:
WIPO Patent Application WO/2013/122178
Kind Code:
A1
Abstract:
The purpose of the present invention is to use a protein obtained by fusing a cancer-specific antigen and a cytokine as a prophylactic or therapeutic agent for cancer. A pharmaceutical composition for preventing or treating cancer, including, as an active ingredient, a protein obtained by fusing a cancer-specific antigen and a cytokine selected from the group consisting of human IL-2 (hIL2), human IL-4 (hIL4), human IL-7 (hIL7), human GMCSF (hGMCSF), mouse IL-4 (mIL4), and mouse GMCSF (mGMCSF).
Inventors:
WATANABE MASAMI (JP)
KUMON HIROMI (JP)
NASU YASUTOMO (JP)
KUMON HIROMI (JP)
NASU YASUTOMO (JP)
Application Number:
PCT/JP2013/053613
Publication Date:
August 22, 2013
Filing Date:
February 15, 2013
Export Citation:
Assignee:
UNIV OKAYAMA NAT UNIV CORP (JP)
International Classes:
A61K38/00; A61K35/12; A61K38/16; A61K39/00; A61P9/00; A61P11/00; A61P13/00; A61P25/00; A61P31/00; A61P35/00; A61P37/00; C12N5/077; C12N5/078; C12N15/09
Domestic Patent References:
| WO2011062298A1 | 2011-05-26 |
Foreign References:
| JP2005513040A | 2005-05-12 | |||
| JP2009544724A | 2009-12-17 |
Other References:
THE JOURNAL OF IMMUNOLOGY, vol. 513, no. 10, 1994, pages 4775 - 4787
NATURE BIOTECHNOLOGY, vol. 27, 2009, pages 129 - 139
NATURE BIOTECHNOLOGY, vol. 27, 2009, pages 129 - 139
Attorney, Agent or Firm:
HIRAKI Yusuke et al. (JP)
Yusuke Hiraki (JP)
Yusuke Hiraki (JP)
Download PDF:
Claims: